A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 13,237 shares of ALNY stock, worth $3.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,237
Previous 2,047 546.65%
Holding current value
$3.6 Million
Previous $305,000 954.43%
% of portfolio
0.04%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $1.6 Million - $2.76 Million
11,190 Added 546.65%
13,237 $3.22 Million
Q1 2024

May 15, 2024

SELL
$146.51 - $198.2 $1.28 Million - $1.74 Million
-8,762 Reduced 81.06%
2,047 $305,000
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $1.17 Million - $1.52 Million
7,727 Added 250.71%
10,809 $2.07 Million
Q3 2023

Nov 14, 2023

SELL
$170.77 - $211.65 $132,346 - $164,028
-775 Reduced 20.09%
3,082 $545,000
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $232,927 - $266,970
-1,259 Reduced 24.61%
3,857 $732,000
Q1 2023

May 15, 2023

BUY
$182.66 - $235.53 $316,001 - $407,466
1,730 Added 51.09%
5,116 $1.02 Million
Q4 2022

Feb 14, 2023

BUY
$185.53 - $241.31 $556 - $723
3 Added 0.09%
3,386 $804,000
Q3 2022

Nov 14, 2022

BUY
$138.54 - $232.0 $38,375 - $64,264
277 Added 8.92%
3,383 $677,000
Q2 2022

Aug 15, 2022

BUY
$120.42 - $169.29 $217,719 - $306,076
1,808 Added 139.29%
3,106 $453,000
Q1 2022

May 16, 2022

BUY
$127.18 - $173.91 $165,079 - $225,735
1,298 New
1,298 $212,000
Q2 2020

Aug 13, 2020

SELL
$104.21 - $156.44 $465,193 - $698,348
-4,464 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$93.12 - $133.99 $143,777 - $206,880
1,544 Added 52.88%
4,464 $486,000
Q4 2019

Feb 14, 2020

BUY
$74.51 - $124.23 $217,569 - $362,751
2,920 New
2,920 $336,000
Q4 2017

Feb 14, 2018

SELL
$114.49 - $139.98 $286,110 - $349,810
-2,499 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$72.53 - $118.27 $181,252 - $295,556
2,499
2,499 $294,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.